SPRY
ARS Pharmaceuticals·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
SPRY fundamentals
ARS Pharmaceuticals (SPRY) released its earnings on Nov 10, 2025: revenue was 32.50M (YoY +1471.57%), beat estimates; EPS was -0.52 (YoY -160.00%), missed estimates.
Revenue / YoY
32.50M
+1471.57%
EPS / YoY
-0.52
-160.00%
Report date
Nov 10, 2025
SPRY Earnings Call Summary for Q3,2025
- Revenue Surge: Q3 U.S. net product revenue up 2.5x Q2 to $31.3M, driven by virtual prescribing program and institutional sales.
- Virtual Access Breakthrough: Get neffy on Us program removes HCP time barriers, with 0 co-pay for insured patients.
- Global Expansion Funding: $250M term loan provides liquidity for 2026 global launches in Japan, Canada, China.
- Clinical Growth Engine: Phase IIb urticaria trial targeting 2M U.S. patients on track for mid-2026 readout.
- Market Share Resilience: Q4 sales expected to resume growth despite seasonal decline, supported by $288M cash position.
EPS
Revenue
Revenue & Expenses
SPRY has released its 2025 Q3 earnings report, with revenue of 32.50M, reflecting a YoY change of 1471.62%, and net profit of -51.15M, showing a YoY change of -167.41%. The Sankey diagram below clearly presents SPRY's revenue sources and cost distribution.
Key Indicators
ARS Pharmaceuticals (SPRY) key financial stats and ratios, covering profitability, financial health, and leverage.
ARS Pharmaceuticals (SPRY)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
ARS Pharmaceuticals (SPRY)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
ARS Pharmaceuticals (SPRY)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does ARS Pharmaceuticals (SPRY) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track ARS Pharmaceuticals (SPRY) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the revenue and EPS growth rate for ARS Pharmaceuticals year over year?What is ARS Pharmaceuticals's gross profit margin?What were the key takeaways from ARS Pharmaceuticals's earnings call?Did ARS Pharmaceuticals beat or miss consensus estimates last quarter?What does ARS Pharmaceuticals do and what are its main business segments?What guidance did ARS Pharmaceuticals's management provide for the next earnings period?What is the market's earnings forecast for ARS Pharmaceuticals next quarter?What were the key takeaways from ARS Pharmaceuticals’s earnings call?
